AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Highlights:
Tilray Brands is active on the S&P/TSX Composite Index.
The company announced its first shipment to the Italian pharmaceutical market.
Tilray Brands continues to expand its international medical cannabis operations.
Tilray Brands (TSX:TLRY), listed on the S&P/TSX Composite Index, operates within the healthcare sector. The company is focused on cannabis production and distribution for medical and recreational use. Tilray Brands manages operations across multiple international markets with activities centered on the development and supply of cannabis-based products.
Entry into the Italian Pharmaceutical Market
Tilray Brands recently announced its first shipment of medical cannabis to the Italian pharmaceutical market. This development marks a new step for the company as it expands its reach within Europe. The shipment supports the company's international supply strategy, with products being made available to patients through approved medical channels in Italy.
Expansion of Global Medical Cannabis Distribution
The company’s latest milestone aligns with its ongoing efforts to expand medical cannabis distribution worldwide. Tilray Brands continues to supply medical markets in various countries, with a focus on maintaining compliance with regulatory frameworks across its regions of operation. The Italian entry adds to the company’s presence in European healthcare markets.
Tilray’s International Operations and Facilities
Tilray Brands operates multiple production and processing facilities across North America and Europe. The company’s global infrastructure supports the cultivation, manufacturing, and distribution of its products. Tilray Brands emphasizes maintaining consistent quality across all regions while adhering to local regulations and standards.
Continued Product Distribution Across Markets
Tilray Brands remains active in distributing medical cannabis to various international markets. The company is engaged in building its supply chains and supporting distribution networks across Europe and North America. Tilray’s approach focuses on advancing its pharmaceutical-grade cannabis operations while maintaining a broad international presence.
